Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06401551 · ClinicalTrials.gov registry record · NA
Clareon PanOptix Pro vs. Clareon PanOptix - Study B
A NA study of Presbyopia and Aphakia, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 8
- Study locations
NCT06401551 is a NA study of Presbyopia and Aphakia that has completed, run by Alcon Research. The registered enrollment target is 71 participants, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (74% lower). The trial reports 8 study locations across 8 states.
The verdict
NCT06401551, a NA study of Presbyopia and Aphakia, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™ PanOptix™ Trifocal IOL.
Conditions Studied
Interventions
- DEVICE CPO Pro IOL
- DEVICE CPO IOL
- PROCEDURE Cataract Surgery
Study Locations (8)
California
- Wolstan & Goldberg Eye Associates - Torrance
Michigan
- Grosinger, Spigelman & Grey Eye Surgeons, P.C. - Bloomfield Hills
Missouri
- Moyes Eye Center - Kansas City
Ohio
- Cincinnati Eye Institute - Cincinnati
South Carolina
- Carolina Eye Care Physicians - Charleston
Tennessee
- Vision for Life - Nashville
Texas
- Houston Eye Associates - Houston
Utah
- The Eye Institute of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06401551
The ClinicalTrials.gov registry entry for NCT06401551 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (74% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Presbyopia appearing as the primary indexed condition, and to 3 interventions - of which CPO Pro IOL is the first listed.
NCT06401551 reports 8 study locations spanning 8 distinct geographic areas - top geographies include California, Michigan, Missouri.
Frequently Asked Questions
What is clinical trial NCT06401551 about?
NCT06401551 is a clinical study titled "Clareon PanOptix Pro vs. Clareon PanOptix - Study B". The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™ PanOptix™ Trifocal IOL.
What is the current status of trial NCT06401551?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2024-06-18. Estimated completion is 2025-04-30.
What conditions does trial NCT06401551 study?
This clinical trial studies the following conditions: Presbyopia, Aphakia.
What interventions are being tested in trial NCT06401551?
The interventions under investigation include: CPO Pro IOL (DEVICE), CPO IOL (DEVICE), Cataract Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT06401551?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06401551 being conducted?
This trial has 8 study locations across California, Michigan, Missouri, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.